In this interview, Dr. Burt discusses the nuanced treatment of bipolar disorder during the perinatal period, emphasizing the importance of satisficing and shared decision-making. She advocates for the continued use of lithium when effective, highlighting the importance of close monitoring and precautions to avoid toxicity. Dr. Burt addresses using other mood stabilizers, such as lamotrigine, carbamazepine, and valproate. She also touches on the use of newer antipsychotics and managing rapid cycling bipolar disorder, promoting personalized and vigilant care to maintain stability in pregnant women with bipolar disorder.
- Provider:Medical Academy, LLC
- Activity Link: https://psychopharmacologyinstitute.com/publication/perinatal-treatment-of-bipolar-disorder-interview-2815?utm_source=PARS+ACCME&utm_medium=PARS+ACCME&utm_campaign=PARS+ACCME
- Start Date: 2024-07-01 05:00:00
- End Date: 2024-07-01 05:00:00
- Credit Details: AMA PRA Category 1 Credit™️: 0.5 hours
- Commercial Support: No
- Activity Type: Enduring Material
- CME Finder Type: Online Learning
- Fee to Participate: Yes
- Measured Outcome: Learner Performance
- Provider Ship: Jointly Provided
- Registration: Limited
Subscribe
Login
0 Comments
Oldest